TET2 and acute myeloid leukemia: AML samples with TET2, IDH1, or IDH2 mutations had lower calculated 5hmC levels at IDHmut DMRs compared to AMLs that were wild type for these genes (Fig. 3E, S2I, J), providing evidence that these mutations influence methylation turnover at these loci.